Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

156
Delayed Quote. Delayed CHI-X EUROPE LIMITED. - 09/18 05:27:54 pm
88.4000 CHF   -0.56%
35m ago Bayer hits record high on move to list plastics business
11h ago NOVARTIS : Keep eye health in vision
1d ago PAUL ALLEN : Patent Issued for Crystalline Forms of 4-Methyl-N--3-(4-Pyr-....
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
09/12/2014 09/15/2014 09/16/2014 09/17/2014 09/18/2014 Date
87.6(c) 88.1(c) 87.75(c) 88.9(c) 88.45 Last
4 911 198 4 063 547 4 115 433 5 555 807 5 306 109 Volume
-0.62% +0.57% -0.40% +1.31% -0.51% Change
More quotes
Company
Novartis AG manufactures and markets health care and nutritional products. It provides innovative healthcare solutions and offers innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. The company... 
Sector
Pharmaceuticals
Calendar
10/28Earnings Release
Surperformance© rating of Novartis AG
Trading Rating : Investor Rating :
More about the company
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 59 096 M
EBIT 2014 13 768 M
Net income 2014 10 500 M
Debt 2014 4 428 M
Yield 2014 2,87%
Sales 2015 57 975 M
EBIT 2015 14 515 M
Net income 2015 11 631 M
Debt 2015 7 487 M
Yield 2015 3,10%
PER 2014 22,34
PER 2015 20,27
EV / Sales 2014 4,44x
EV / Sales 2015 4,58x
Capitalization 258 051 M
More Financials
Latest news on NOVARTIS AG
35m ago Bayer hits record high on move to list plastics business
11h ago NOVARTIS : Keep eye health in vision
1d ago PAUL ALLEN : Patent Issued for Crystalline Forms of 4-Methyl-N--3-(4-Pyr-...
1d ago For Roche CEO, celebrating failure is key to success
1d ago Court grants novartis temporary injunction against ranbaxy
1d ago NOVARTIS : to tackle climate change with Sichuan tree planting project
1d ago NOVARTIS : presents oncology research advances with new data on Zykadia(TM), Afi..
1d ago NOVARTIS : presents oncology research advances with new data on Zykadia(TM), Afi..
2d ago NOVARTIS : China Valsartan Hydrochlorothiazide Market Analysis & Forecast Resear..
2d ago NOVARTIS : Ari Gnanasakthy, Karoly Kulich Join RTI Health Solutions Adding Decad..
3d ago NOVARTIS : CONTRACT AWARD - 65-- Oxazepam Capsules Sandoz, Inc Effective: 9/22/2..
3d ago NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
Novartis AG : Income Statement Evolution
More Financials
EPS Revisions
Novartis AG : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF